NCT00846846View on ClinicalTrials.gov

PROTECT Continued Access Post Marketing Surveillance Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

1,018

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2015

Conditions
Coronary Artery Disease, Autosomal Dominant, 1
Interventions
DEVICE

Endeavor® Zotarolimus Eluting Coronary Stent System

Endeavor® Zotarolimus Eluting Coronary Stent System in a patient population requiring stent implantation

Trial Locations (1)

01605

University of Massachusetts Memorial Medical Center, Worcester

Sponsors

Lead Sponsor

Medtronic Vascular
All Listed Sponsors
lead

Medtronic Vascular

INDUSTRY

NCT00846846 - PROTECT Continued Access Post Marketing Surveillance Trial | Biotech Hunter | Biotech Hunter